Home » Topics » Disease categories and therapies » Neurology/psychiatric

Neurology/psychiatric
RSS

Neurogen scientists synthesize new series of brain GABA-A receptor ligands

Jan. 15, 2001

Abbott designs modulators of neurotransmitter release for therapeutic use

Jan. 15, 2001

Impact of SERMs on stroke examined in rat model using LY-353381.HCl

Jan. 15, 2001

DepoMorphine enters late-stage development at SkyePharma

Jan. 15, 2001

Cell Genesys creates CNS gene therapy subsidiary

Jan. 15, 2001

Seven-day transdermal analgesic to be developed by 3M and Purdue

Jan. 15, 2001

Neurocrine's insomnia agent shows fewer next-day adverse effects than conventional drugs

Jan. 15, 2001

The former Allelix Neuroscience issued patent for new GlyT-2 transporter inhibitors

Jan. 15, 2001

Theratechnologies seeks clearance to initiate two additional trials with ThGRF1-44

Jan. 12, 2001

Prototypical selective mglu5 antagonist displays anxiolytic-like effects

Jan. 12, 2001

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 26, 2026.
Brain-computer interfaces are here but long road ahead
BioWorld
The field of BCI is continually evolving; as such, companies are increasingly highlighting the potential of their technologies to transform care. For advanced...
Next wave of BCI firms builds on pioneers to tackle challenges
BioWorld
With the pace of neurotechnology development accelerating, a wave of brain-computer interface (BCI) companies is emerging on the heels of the pioneers. In the...
Boehringer Ingelheim identifies new mGlu3 receptor agonists
BioWorld Science
Boehringer Ingelheim Pharma GmbH & Co. KG and Vanderbilt University have discovered new dihydrobenzoxazine compounds acting as metabotropic glutamate mGlu3...
ENCALS 2026: From genetics to advancing strategies against ALS
BioWorld Science
Amyotrophic lateral sclerosis (ALS)-associated genes provide direct therapeutic targets and reveal pathways that can be used to develop treatments that counteract...